UNSPSC 51171966: Geranylgeranylacetone or teprenone

This classification denotes an anti-ulcer agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8S8451A4O. European Medicines Agency schedules Teprenone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15486MIG. Teprenone generally arises in the molecular formula C23H38O.

The term TEPRENONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) TEPRENONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Geranylgeranylacetone or teprenone bears US NLM identifiers UMLS ID C0061231 and NCI Concept Code C66587. SMILES: CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C.

UNSPSC 51171966 Geranylgeranylacetone or teprenone is a Commodity code that nominally describes a specific pharmaceutical compound, but recent state and local procurement activity under this code does not reflect purchases of that substance. The three posted opportunities—a Collin County Community Supervision and Corrections Department drug testing RFP, a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs, and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products—address specimen collection services, pharmacy benefit program design, and broad pharmaceutical supply respectively, none of which align with procurement of geranylgeranylacetone or teprenone specifically. The code shows little relevant recent activity, suggesting either sparse utilization, misclassification of posted opportunities, or minimal state and local demand for this particular pharmaceutical ingredient.

The geographic spread of recent opportunities spans Texas and Minnesota through state-level issuing bodies and regional cooperative purchasing vehicles. The representative recent solicitations include Collin County's RFP 2026-327 for offender specimen collection and drug testing services (RFP, due July 23, 2026, estimated contract value $600,000), the Texas HHS Commission's RFI HHS0017013 on direct-to-manufacturer prescriptions (RFI, response deadline April 3, 2026), and MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products (RFP, due March 26, 2026). None of these opportunities target procurement of geranylgeranylacetone or teprenone, indicating that the code assignment may not reflect actual procurement intent or that state and local governments are not sourcing this substance through these channels.